Literature DB >> 9121362

Role of m1 receptor-G protein coupling in cell proliferation in the prostate.

G R Luthin1, P Wang, H Zhou, D Dhanasekaran, M R Ruggieri.   

Abstract

The prostate gland from several animal species contains variable levels of muscarinic subtypes, but only the human prostate expresses significant levels of the m1 subtype. We studied muscarinic receptor activity in human benign prostatic hypertrophy (BPH) as well as several cell lines derived from prostate cancer. The BPH we studied expresses approximately 75% of the m1 receptor and undetectable levels of the other receptor subtypes whereas PC3 cells express only the m3 receptor subtype. DU145 and LnCaP cells express approximately equal levels of m1 and m3 receptor subtypes. Only the PC3 cells responded to carbachol with an increase in turnover of polyphosphoinositides, and none of the cell lines responded with effects on cAMP metabolism. Co-precipitation of receptors with heterotrimeric guanine nucleotide-binding regulatory proteins demonstrated interactions of the m1 receptors with Gi, Gq and G16 in BPH tissue and of the m1 and m3 receptors with Gi, Gq and G12 in PC3 and DU145 cells. Mitogen activated protein kinase (ERK) activity was seen in response to carbachol in PC3 and DU145 but not LnCaP cells. Finally, carbachol promoted cell proliferation in all three cell lines. Thus, there appears to be no consistent relationship between ERK activity, cell proliferation, and the subtype mediating the proliferative response, amongst these prostate cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121362      PMCID: PMC3277865          DOI: 10.1016/s0024-3205(97)00035-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  G protein-coupled receptor systems involved in cell growth and oncogenesis.

Authors:  N Dhanasekaran; L E Heasley; G L Johnson
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

2.  Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.

Authors:  W Lee; B B Wolfe
Journal:  Mol Pharmacol       Date:  1989-11       Impact factor: 4.436

3.  Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor.

Authors:  T Kubo; K Fukuda; A Mikami; A Maeda; H Takahashi; M Mishina; T Haga; K Haga; A Ichiyama; K Kangawa
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

4.  Potent transforming activity of the G13 alpha subunit defines a novel family of oncogenes.

Authors:  N Xu; T Voyno-Yasenetskaya; J S Gutkind
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

5.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

6.  Human prostate muscarinic receptor subtypes.

Authors:  M R Ruggieri; M D Colton; P Wang; J Wang; R J Smyth; M A Pontari; G R Luthin
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

7.  Activation of Jun kinase/stress-activated protein kinase by GTPase-deficient mutants of G alpha 12 and G alpha 13.

Authors:  M V Prasad; J M Dermott; L E Heasley; G L Johnson; N Dhanasekaran
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

  7 in total
  12 in total

1.  Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells.

Authors:  V Sydorenko; Y Shuba; S Thebault; M Roudbaraki; G Lepage; N Prevarskaya; R Skryma
Journal:  J Physiol       Date:  2003-05-01       Impact factor: 5.182

Review 2.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

Review 3.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

4.  Cholinergic facilitation of neurotransmission to the smooth muscle of the guinea-pig prostate gland.

Authors:  W A Lau; J N Pennefather; F J Mitchelson
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 5.  Muscarinic receptor agonists and antagonists: effects on cancer.

Authors:  Eliot R Spindel
Journal:  Handb Exp Pharmacol       Date:  2012

Review 6.  Muscarinic acetylcholine receptor subtypes in the male reproductive tract: expression and function in rat efferent ductules and epididymis.

Authors:  Maria Christina W Avellar; Erica R Siu; Fabiana Yasuhara; Elisabeth Maróstica; Catarina S Porto
Journal:  J Mol Neurosci       Date:  2009-08-20       Impact factor: 3.444

7.  Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors.

Authors:  Huayun Deng; Haiyan Sun; Ye Fang
Journal:  J Pharmacol Toxicol Methods       Date:  2013-08-09       Impact factor: 1.950

8.  Cholinergic receptor alterations in the brain stem of spinal cord injured rats.

Authors:  Chinthu Romeo; Anju Thoppil Raveendran; Nandhu Mohan Sobha; Cheramadathukuzhiyil Scaria Paulose
Journal:  Neurochem Res       Date:  2012-11-27       Impact factor: 3.996

Review 9.  Use of botulinum toxin for voiding dysfunction.

Authors:  David Eldred-Evans; Prokar Dasgupta
Journal:  Transl Androl Urol       Date:  2017-04

10.  Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling.

Authors:  Qing-Qing Yin; Lin-Hui Xu; Mi Zhang; Chen Xu
Journal:  Asian J Androl       Date:  2018 Nov-Dec       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.